Literature DB >> 301573

A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.

J Minowada, T Tsubota, M F Greaves, T R Walters.   

Abstract

A permanent hematopoietic cell line, designated NALM-1, was established from the peripheral blood of a patient who was in blastic crisis of Ph1-positive chronic myleocytic leukemia. By means of a panel of specific xenoantisera, the NALM-1 cells were found to express a specific antigen of acute lymphoblastic leukemia and blast leukemia-associated antigen. The cells exhibited no cell-surface receptors for sheep erythrocytes, IgG, or complement; neither cell-surface immunoglobulins nor cytoplasmic immunoglobulin were observed. Furthermore, normal T-cell or B-cell antigens, detectable by the antisera used in this study, were not found in the NALM-1 line.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301573     DOI: 10.1093/jnci/59.1.83

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  36 in total

1.  Establishment and characterization of new B-cell precursor leukemia cell line NALM-35.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Akira Harashima; Nobuharu Fujii; Fumihiko Ishimaru; Kunzo Orita
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

2.  Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Authors:  A L Lattion; E Espel; P Reichenbach; C Fromental; P Bucher; A Israël; P Baeuerle; N R Rice; M Nabholz
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.

Authors:  Emily F Mason; Yuxing Zhao; Pankuri Goraksha-Hicks; Jonathan L Coloff; Hugh Gannon; Stephen N Jones; Jeffrey C Rathmell
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

4.  mRNA transcripts initiating within the human immunoglobulin mu heavy chain enhancer region contain a non-translatable exon and are extremely heterogeneous at the 5' end.

Authors:  G A Neale; G R Kitchingman
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

5.  Bidirectional transcription from the human immunoglobulin VH6 gene promoter.

Authors:  Z Sun; G R Kitchingman
Journal:  Nucleic Acids Res       Date:  1994-03-11       Impact factor: 16.971

6.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  Molecular footprints of human immunoglobulin gene evolution: a new sequence family.

Authors:  B Straubinger; M Pech; K Mühlebach; H R Jaenichen; H G Bauer; H G Zachau
Journal:  Nucleic Acids Res       Date:  1984-07-11       Impact factor: 16.971

8.  Insulin requirement of human leukemic cell lines.

Authors:  G Garbarino; G L Pagliardi; A Palumbo; G Turco; L Pegoraro
Journal:  Experientia       Date:  1985-08-15

9.  Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.

Authors:  A T Look; S L Melvin; L K Brown; M E Dockter; P K Roberson; S B Murphy
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia.

Authors:  L M Nadler; J Ritz; M P Bates; E K Park; K C Anderson; S E Sallan; S F Schlossman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.